American Clinical Research Services (ACRS) appointed Dustin Owen Chief Executive Officer.

Owen joins the company from Thermo Fisher Scientific/PPD, where he was senior vice president and general manager of Accelerated Enrollment Solutions (AES), which offers biopharmaceutical sponsors and contract research organizations clinical trial site conduct and patient access solutions. In his role, Owen was responsible for more than 160 clinical research sites, spanning 15 countries and 2,000 employees.

Prior to leading AES at Thermo Fisher/PPD, Owen served as PPD’s head of Asia Pacific clinical operations and board member for PPD-SNBL Laboratories joint venture in Japan preceded by vice president of Strategic Laboratory Operations. Prior to joining PPD in 2013, he held roles at LabCorp, Biogen, and Manhattan Associates.

ACRS was formed in 2022 by Latticework Capital Management with the acquisition of Catalina Research Institute (CRI). CRI focuses on highly complex metabolic trials in NASH, NAFLD, and diabetes, along with central nervous system disease.

In Jan 2023, ACRS acquired patient recruitment company Clinical Site Services (CSSi), along with subsidiary Patient Advertising Guru. CSSi leverages media outreach and local enrollment specialists to raise awareness of clinical trials.

“We are delighted to have Dustin join the ACRS team as CEO as we seek to build out a premier management team and corporate infrastructure at ACRS,” said, Kyle Bradford, Managing Partner at Latticework Capital. “Dustin has a unique background having led a large organization focused on both clinical trial execution and patient recruitment. His experience will be additive as we build out a full-service site management organization.”